000			02010 a2200589 4500
005			20250515055619.0
264		0	_c20070626
008			200706s 0 0 eng d
022			_a0007-0963
024	7		_a10.1111/j.1365-2133.2007.07682.x _2doi
040			_aNLM _beng _cNLM
100	1		_aLee, H-H
245	0	0	_aCutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists. _h[electronic resource]
260			_bThe British journal of dermatology _cMar 2007
300			_a486-91 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdalimumab
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal _xadverse effects
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntirheumatic Agents _xadverse effects
650	0	4	_aDermatitis, Atopic _xchemically induced
650	0	4	_aDrug Eruptions _xetiology
650	0	4	_aEtanercept
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunoglobulin G _xadverse effects
650	0	4	_aImmunologic Factors _xadverse effects
650	0	4	_aInfliximab
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOpportunistic Infections _xchemically induced
650	0	4	_aProspective Studies
650	0	4	_aPsoriasis _xchemically induced
650	0	4	_aReceptors, Tumor Necrosis Factor
650	0	4	_aRheumatic Diseases _xdrug therapy
650	0	4	_aSkin Diseases, Infectious _xchemically induced
650	0	4	_aTumor Necrosis Factor-alpha _xantagonists & inhibitors
700	1		_aSong, I-H
700	1		_aFriedrich, M
700	1		_aGauliard, A
700	1		_aDetert, J
700	1		_aRöwert, J
700	1		_aAudring, H
700	1		_aKary, S
700	1		_aBurmester, G-R
700	1		_aSterry, W
700	1		_aWorm, M
773	0		_tThe British journal of dermatology _gvol. 156 _gno. 3 _gp. 486-91
856	4	0	_uhttps://doi.org/10.1111/j.1365-2133.2007.07682.x _zAvailable from publisher's website
999			_c16859685 _d16859685